Status:
RECRUITING
RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Huashan Hospital
Conditions:
Basal Ganglia Hemorrhage
Intraventricular Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Intracerebral hemorrhage (ICH) is one of the most devastating forms of stroke, with high rates of death and disability worldwide. Despite advances in medical and surgical care, effective therapeutic o...
Detailed Description
Intracerebral hemorrhage (ICH) is a leading cause of stroke-related mortality and long-term disability worldwide. Conventional surgical techniques, including craniotomy and catheter-based drainage, ar...
Eligibility Criteria
Inclusion
- Umbrella Trial
- Age ≥18 years；
- Clinical diagnosis of spontaneous hemorrhagic stroke；
- Umbrella Trial
Exclusion
- 1\. Radiologically diagnosed cerebrovascular abnormalities, as well as ischemic infarction converting to intracerebral hemorrhage, or recent (within 1 year) recurrence of intracerebral hemorrhage；
- Each substudy will specify additional inclusion and exclusion criteria in the respective Substudy-specific Registration. Patients who fulfill the overall umbrella trial criteria will be assessed for enrollment into each substudy.
Key Trial Info
Start Date :
September 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07205263
Start Date
September 30 2025
End Date
December 1 2027
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310000